DERMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Journey Medical Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$5.17+0.21 (+4.13%)
Close on Oct 19, 2026
- Market cap
- $142.14M
- P/E (TTM)
- –
- Dividend yield
- –
Journey Medical statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Journey Medical | Industry median |
|---|---|---|
| Market Cap | $145.92M | $164.85M |
| Enterprise Value | $145.75M | $87.06M |
| PS Ratio | 2.14 | 3.60 |
| PB Ratio | 4.54 | 2.03 |
| P/TBV Ratio | 22.10 | 2.31 |
Enterprise value
| Measure | Journey Medical | Industry median |
|---|---|---|
| EV / Sales | 2.14 | 2.43 |
Income (trailing twelve months)
| Measure | Journey Medical | Industry median |
|---|---|---|
| Revenue | $68.18M | $57.94M |
| Gross Profit | $44.63M | $90.47M |
| Operating Income | -$3.01M | -$21.44M |
| Pretax Income | -$6.09M | -$14.45M |
| Net Income | -$6.10M | -$22.46M |
| EBITDA | -$3.01M | -$16.91M |
| EPS (Diluted) | -$0.23 | -$0.83 |
Margins
| Measure | Journey Medical | Industry median |
|---|---|---|
| Gross Margin | 65.5% | 52.3% |
| Operating Margin | -4.41% | -44.5% |
| Pretax Margin | -8.93% | -13.0% |
| Profit Margin | -8.95% | -39.2% |
| EBITDA Margin | -4.41% | -31.3% |
Returns
| Measure | Journey Medical | Industry median |
|---|---|---|
| Return on Equity (ROE) | -23.8% | -53.1% |
| Return on Assets (ROA) | -6.80% | -41.0% |
| Return on Invested Capital (ROIC) | -8.49% | -32.0% |
| Return on Capital Employed (ROCE) | -5.72% | -37.8% |
Growth
| Measure | Journey Medical | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 20.9% | 6.01% |
| Revenue Growth (3Y CAGR) | -5.66% | 2.25% |
| Revenue Growth (5Y CAGR) | 6.79% | 6.42% |
Balance sheet
| Measure | Journey Medical | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $25.64M | $62.42M |
| Total Debt | $25.47M | $120.13M |
| Net Cash (Debt) | $171.00K | $15.68M |
| Net Cash Per Share | $0.01 | $0.66 |
| Equity (Book Value) | $32.11M | $48.79M |
| Book Value Per Share | $1.14 | $1.36 |
| Tangible Book Value | $6.60M | $23.06M |
| Working Capital | $27.01M | $75.77M |
Financial position
| Measure | Journey Medical | Industry median |
|---|---|---|
| Current Ratio | 1.59 | 3.30 |
| Quick Ratio | 1.35 | 2.39 |
| Debt / Equity | 0.79 | 0.51 |
| Interest Coverage | -0.82 | -7.12 |
Cash flow (trailing twelve months)
| Measure | Journey Medical | Industry median |
|---|---|---|
| Operating Cash Flow | -$7.49M | -$12.35M |
Efficiency
| Measure | Journey Medical | Industry median |
|---|---|---|
| Asset Turnover | 0.76 | 0.38 |
| Inventory Turnover | 2.24 | 2.67 |
| Revenue Per Employee | $1.18M | $398.96K |
| Profits Per Employee | -$105.24K | -$703.34K |
| Employee Count | 58 | 74 |
Dividends and yields
| Measure | Journey Medical | Industry median |
|---|---|---|
| Earnings Yield | -4.18% | -22.7% |
Shares
| Measure | Journey Medical | Industry median |
|---|---|---|
| Shares Outstanding | 28,224,400 | 58,179,650 |
| Shares Change (YoY) | 21.8% | 11.1% |
| Float | 23,894,800 | 49,173,100 |
| Shares Held by Insiders | 15.3% | 11.6% |
| Shares Held by Institutions | 37.8% | 59.4% |
Scores
| Measure | Journey Medical | Industry median |
|---|---|---|
| Altman Z-Score | 0.81 | -0.24 |
| Piotroski F-Score | 5 | 4 |
Calculated by StockData from Journey Medical's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.